Biblio
. Stem Cell Res. 2018;34:101344.
Analysis of Influenza A virus infection in human induced pluripotent stem cells (hiPSCs) and their derivatives. Virus Res. 2022:199009.
. CRISPR-Cas9-mediated disruption of B2M and CIITA genes eliminates HLA class I and II expression in human induced pluripotent stem cells (MUSIi001-A-2). Stem Cell Res. 2023;71:103138.
. Dual Small-Molecule Targeting of SMAD Signaling Stimulates Human Induced Pluripotent Stem Cells toward Neural Lineages. PLoS One. 2014;9(9):e106952.
. Editorial: Advances in iPSC technology for disease modeling and therapeutic applications. Front Cell Dev Biol. 2023;11:1261279.
. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors. Stem Cell Res. 2018;32:43-46.
. Generation of an induced pluripotent stem cell line (MUSIi014-A) from an affected member of a family with autosomal dominant diabetes carrying p.L475P mutation in ZYG11A gene associated with a cell cycle arrest in beta-cell. Stem Cell Res. 2022;60:102715.
. Generation of an integration-free human induced pluripotent stem cell line MUSIi010-A from occipital scalp fibroblasts of a male patient with androgenetic alopecia. Stem Cell Res. 2019;38:101486.
Generation of two induced pluripotent stem cell lines (MUSIi011-A and MUSIi011-B) from peripheral blood T lymphocytes of a healthy individual. Stem Cell Res. 2019;39:101487.
. . .